NEW YORK (GenomeWeb) – Transgenomic said today that it has received $1.15 million in proceeds from a note bridge financing.
The company will use the funds to complete its merger with Precipio Diagnostics, which is expected to close in the second quarter. The companies announced the intended merger, which will make Precipio a wholly owned subsidiary of Transgenomic, in October.
Get the full story This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?